Eddy Fan1, David W Dowdy, Elizabeth Colantuoni, Pedro A Mendez-Tellez, Jonathan E Sevransky, Carl Shanholtz, Cheryl R Dennison Himmelfarb, Sanjay V Desai, Nancy Ciesla, Margaret S Herridge, Peter J Pronovost, Dale M Needham. 1. 1Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada. 2Outcomes After Critical Illness and Surgery (OACIS) Group, Johns Hopkins University School of Medicine, Baltimore, MD. 3Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 4Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 5Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 6Division of Pulmonary, Allergy, and Critical Care Medicine, Emory University School of Medicine, Atlanta, GA. 7Division of Pulmonary and Critical Care Medicine, University of Maryland, Baltimore, MD. 8Johns Hopkins University School of Nursing, Baltimore, MD. 9Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 10Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 11Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
OBJECTIVE: Survivors of severe critical illness frequently develop substantial and persistent physical complications, including muscle weakness, impaired physical function, and decreased health-related quality of life. Our objective was to determine the longitudinal epidemiology of muscle weakness, physical function, and health-related quality of life and their associations with critical illness and ICU exposures. DESIGN: A multisite prospective study with longitudinal follow-up at 3, 6, 12, and 24 months after acute lung injury. SETTING: Thirteen ICUs from four academic teaching hospitals. PATIENTS: Two hundred twenty-two survivors of acute lung injury. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: At each time point, patients underwent standardized clinical evaluations of extremity, hand grip, and respiratory muscle strength; anthropometrics (height, weight, mid-arm circumference, and triceps skin fold thickness); 6-minute walk distance, and the Medical Outcomes Short-Form 36 health-related quality of life survey. During their hospitalization, survivors also had detailed daily evaluation of critical illness and related treatment variables. Over one third of survivors had objective evidence of muscle weakness at hospital discharge, with most improving within 12 months. This weakness was associated with substantial impairments in physical function and health-related quality of life that persisted at 24 months. The duration of bed rest during critical illness was consistently associated with weakness throughout 24-month follow-up. The cumulative dose of systematic corticosteroids and use of neuromuscular blockers in the ICU were not associated with weakness. CONCLUSIONS: Muscle weakness is common after acute lung injury, usually recovering within 12 months. This weakness is associated with substantial impairments in physical function and health-related quality of life that continue beyond 24 months. These results provide valuable prognostic information regarding physical recovery after acute lung injury. Evidence-based methods to reduce the duration of bed rest during critical illness may be important for improving these long-term impairments.
OBJECTIVE: Survivors of severe critical illness frequently develop substantial and persistent physical complications, including muscle weakness, impaired physical function, and decreased health-related quality of life. Our objective was to determine the longitudinal epidemiology of muscle weakness, physical function, and health-related quality of life and their associations with critical illness and ICU exposures. DESIGN: A multisite prospective study with longitudinal follow-up at 3, 6, 12, and 24 months after acute lung injury. SETTING: Thirteen ICUs from four academic teaching hospitals. PATIENTS: Two hundred twenty-two survivors of acute lung injury. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: At each time point, patients underwent standardized clinical evaluations of extremity, hand grip, and respiratory muscle strength; anthropometrics (height, weight, mid-arm circumference, and triceps skin fold thickness); 6-minute walk distance, and the Medical Outcomes Short-Form 36 health-related quality of life survey. During their hospitalization, survivors also had detailed daily evaluation of critical illness and related treatment variables. Over one third of survivors had objective evidence of muscle weakness at hospital discharge, with most improving within 12 months. This weakness was associated with substantial impairments in physical function and health-related quality of life that persisted at 24 months. The duration of bed rest during critical illness was consistently associated with weakness throughout 24-month follow-up. The cumulative dose of systematic corticosteroids and use of neuromuscular blockers in the ICU were not associated with weakness. CONCLUSIONS:Muscle weakness is common after acute lung injury, usually recovering within 12 months. This weakness is associated with substantial impairments in physical function and health-related quality of life that continue beyond 24 months. These results provide valuable prognostic information regarding physical recovery after acute lung injury. Evidence-based methods to reduce the duration of bed rest during critical illness may be important for improving these long-term impairments.
Authors: Ravi Varadhan; Carlos O Weiss; Jodi B Segal; Albert W Wu; Daniel Scharfstein; Cynthia Boyd Journal: Med Care Date: 2010-06 Impact factor: 2.983
Authors: Naeem A Ali; James M O'Brien; Stephen P Hoffmann; Gary Phillips; Allan Garland; James C W Finley; Khalid Almoosa; Rana Hejal; Karen M Wolf; Stanley Lemeshow; Alfred F Connors; Clay B Marsh Journal: Am J Respir Crit Care Med Date: 2008-05-29 Impact factor: 21.405
Authors: Roger G Spragg; Gordon R Bernard; William Checkley; J Randall Curtis; Ognjen Gajic; Gordon Guyatt; Jesse Hall; Elliott Israel; Manu Jain; Dale M Needham; Adrienne G Randolph; Gordon D Rubenfeld; David Schoenfeld; B Taylor Thompson; Lorraine B Ware; Duncan Young; Andrea L Harabin Journal: Am J Respir Crit Care Med Date: 2010-03-11 Impact factor: 21.405
Authors: Eddy Fan; Nancy D Ciesla; Alex D Truong; Vinodh Bhoopathi; Scott L Zeger; Dale M Needham Journal: Intensive Care Med Date: 2010-03-06 Impact factor: 17.440
Authors: S Nanas; K Kritikos; E Angelopoulos; A Siafaka; S Tsikriki; M Poriazi; D Kanaloupiti; M Kontogeorgi; M Pratikaki; D Zervakis; C Routsi; C Roussos Journal: Acta Neurol Scand Date: 2008-03-18 Impact factor: 3.209
Authors: Catherine L Hough; Kenneth P Steinberg; B Taylor Thompson; Gordon D Rubenfeld; Leonard D Hudson Journal: Intensive Care Med Date: 2008-10-23 Impact factor: 17.440
Authors: Donald F Slack; Douglas S Corwin; Nirav G Shah; Carl B Shanholtz; Avelino C Verceles; Giora Netzer; Kevin M Jones; Clayton H Brown; Michael L Terrin; Jeffrey D Hasday Journal: Crit Care Med Date: 2017-07 Impact factor: 7.598
Authors: Elizabeth R Pfoh; Amy W Wozniak; Elizabeth Colantuoni; Victor D Dinglas; Pedro A Mendez-Tellez; Carl Shanholtz; Nancy D Ciesla; Peter J Pronovost; Dale M Needham Journal: Intensive Care Med Date: 2016-09-16 Impact factor: 17.440
Authors: Krysta S Wolfe; Bhakti K Patel; Erica L MacKenzie; Shewit P Giovanni; Anne S Pohlman; Matthew M Churpek; Jesse B Hall; John P Kress Journal: Chest Date: 2018-09-11 Impact factor: 9.410
Authors: Gary E Weissman; Rebecca A Hubbard; Lyle H Ungar; Michael O Harhay; Casey S Greene; Blanca E Himes; Scott D Halpern Journal: Crit Care Med Date: 2018-07 Impact factor: 7.598
Authors: Sheetal Gandotra; James Lovato; Douglas Case; Rita N Bakhru; Kevin Gibbs; Michael Berry; D Clark Files; Peter E Morris Journal: Ann Am Thorac Soc Date: 2019-04
Authors: Nilesh M Mehta; Lori J Bechard; David Zurakowski; Christopher P Duggan; Daren K Heyland Journal: Am J Clin Nutr Date: 2015-05-13 Impact factor: 7.045
Authors: Sarah Elizabeth Jolley; Marc Moss; Dale M Needham; Ellen Caldwell; Peter E Morris; Russell R Miller; Nancy Ringwood; Megan Anders; Karen K Koo; Stephanie E Gundel; Selina M Parry; Catherine L Hough Journal: Crit Care Med Date: 2017-02 Impact factor: 7.598